Journals / Türk Kardiyoloji Derneği Arşivi / 2011 / Cilt: 39 - Sayı: 3

Serum gamma-glutamiltransferaz aktivitesi: Koroner arter baypas greft hastalığı için yeni bir belirteç

Serum gamma-glutamyltransferase activity: a new marker for coronary artery bypass graft disease

Pages
205–213
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A graft was considered patent if there was 0.05), radial artery grafts and saphenous vein grafts (SVG) with severe graft disease were associated with significantly higher GGT levels (p=0.003 and p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Serum gamma-glutamyltransferase (GGT) activity has been shown to be related to the development of atherosclerosis and cardiovascular events.
📊
Key Findings & Data:Study design: We evaluated 113 patients (mean age 62±9 years; range 21 to 81 years) who underwent control coronary angiography after a mean of 39 months (range 18 to 84 months) following CABG surgery.
💡
Conclusion & Impact:A graft was considered patent if there was 0.05), radial artery grafts and saphenous vein grafts (SVG) with severe graft disease were associated with significantly higher GGT levels (p=0.003 and p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Serum gamma-glutamyltransferase (GGT) activity has been shown to be related to the development of atherosclerosis and cardiovascular events. We evaluated the association between GGT and severe graft disease in patients undergoing coronary artery bypass graft (CABG) surgery. Study design: We evaluated 113 patients (mean age 62±9 years; range 21 to 81 years) who underwent control coronary angiography after a mean of 39 months (range 18 to 84 months) following CABG surgery. A graft was considered patent if there was 0.05), radial artery grafts and saphenous vein grafts (SVG) with severe graft disease were associated with significantly higher GGT levels (p=0.003 and p

Özet

Amaç: Serum gama-glutamiltransferaz (GGT) aktivitesinin ateroskleroz ve kardiyovasküler olayların gelişimi ile ilişkili olduğu gösterilmiştir. Çalışmamızda koroner arter baypas greft (KABG) ameliyatı geçiren hastalarda GGT ve ciddi greft hastalığı arasındaki ilişki değerlendirildi. Çalışma planı: Çalışmaya, KABG cerrahisi geçirmiş ve ortalama 39 ay (dağılım 18-84 ay) sonra kontrol koroner anjiyografi uygulanan 113 hasta (ort. yaş 62±9; dağılım 21-81) alındı. Kontrol koroner anjiyografide %70’in altında darlık greftin açık olması, %70’in üzerinde darlık ise ciddi greft hastalığı olarak değerlendirildi. Tüm hastalarda KABG öncesinde serum GGT düzeyleri ölçülmüştü ve hiçbirinde ciddi sistemik ya da hepatobiliyer hastalık yoktu. Serum GGT düzeyi ve ciddi greft hastalığı arasındaki ilişki araştırıldı. Greftler, ciddi hastalık gelişimi açısından ayrı olarak da değerlendirildi.Bulgular: Koroner anjiyografide 65 hastada (%57.5) en az bir greftte ciddi hastalık saptandı. Serum GGT düzeyi ciddi greft hastalığı olan grupta anlamlı derecede daha yüksekti (p=0.001). ROC analizinde ciddi greft hastalığı gelişimi açısından serum GGT düzeyi için sınır değer 29.5 U/l ve eğri altında kalan alan 0.69 olarak hesaplandı ve duyarlık %48, özgüllük %82 bulundu. İnternal mamaryan arter greftlerinde GGT düzeyi farklılık göstermezken (p>0.05), radiyal arter greftlerinde ve safen ven greftlerinde (SVG) GGT düzeyi ciddi greft hastalığı olanlarda anlamlı derecede daha yüksekti (sırasıyla, p=0.003 ve p

🔖

Cite This Article

SEZGİN, A., BALTA, Ş., YILDIRIR, A., ÖZİN, B., MÜDERİSOĞLU, H., ULUS, T., SADE, L. E. (2022). Serum gamma-glutamiltransferaz aktivitesi: Koroner arter baypas greft hastalığı için yeni bir belirteç. Türk Kardiyoloji Derneği Arşivi, Cilt: 39 - Sayı: 3, 205–213. https://ajindex.com/articles/633204

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Morrow DA, Gersh BJ, Braunwald E. Chronic coronary artery disease. In: Zipes DP, Libby P, Bonow RO, Braunwald E, editors. Braunwald’s heart disease: a textbook of cardiovascular medicine. 7th ed. Philadelphia: Elsevier Saunders; 2005. p. 1281-1354
  2. Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol 2004;44:2149-56
  3. Peykar S, Angiolillo DJ, Bass TA, Costa MA. Saphenous vein graft disease. Minerva Cardioangiol 2004;52:379-90
  4. Weinschelbaum EE, Macchia A, Caramutti VM, Machain HA, Raffaelli HA, Favaloro MR, et al. Myocardial revascularization with radial and mammary arteries: initial and mid-term results. Ann Thorac Surg 2000;70:1378-83
  5. Khot UN, Friedman DT, Pettersson G, Smedira NG, Li J, Ellis SG. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts. Circulation 2004;109:2086-91
  6. Rahman I, MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 2000; 16:534-54
  7. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003;49:1358-66
  8. Drozdz R, Parmentier C, Hachad H, Leroy P, Siest G, Wellman M. gamma-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med 1998;25:786-92
  9. Paolicchi A, Minotti G, Tonarelli P, Tongiani R, De Cesare D, Mezzetti A, et al. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation-a potential mechanism in atherosclerosis. J Investig Med 1999;47:151-60
  10. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26
  11. Reid VC, Mitchinson MJ. Toxicity of oxidised low density lipoprotein towards mouse peritoneal macrophages in vitro. Atherosclerosis 1993;98:17-24
  12. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996;98:2572-9
  13. Aviram M. Modified fo